Frontiers | The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text,Current and Future Perspectives of PDL1 PET and SPECT Imaging - ScienceDirect,Frontiers | The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers,Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy | Molecular Cancer | Full Text